# US 9,518,292 B2 · Methods for suppression PCR > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 9,518,292 B2 - Document ID: US9518292B2 - Status: Granted - Kind: B2 - Application number: 14/119,471 - Filed: 2012-05-25 - Published: 2014-10-23 - Granted: 2016-12-13 - Earliest claimed: 2011-05-26 - Assignees: Brandeis University - Applicants: Ken Sugino; Serena David; Saori Kato; Sean O'Toole; Sacha Nelson - Inventors: Ken Sugino; Serena David; Saori Kato; Sean O'Toole; Sacha Nelson - Web page: https://patentgrep.com/patent/US9518292B2 ## CPC - C12Q 1/686: Polymerase chain reaction [PCR] - C12Q 1/6858: Allele-specific amplification - C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES ## Abstract Provided herein are approaches for the detection, identification, and/or selective amplification of specific target species or target variants of nucleic acid sequences, even within an excess of unwanted similar sequences or variants. These approaches include methods, assays, and kits for suppression PCR that require, in part, DNA polymerase that lacks 5′-3′ exonuclease activity, and a PCR primer, termed a forward selective primer or a nunchaku primer. The methods, assays, and kits provided herein are useful for a wide variety of applications, including cancer screening assays and kits, personalized screening assays, SNP (single nucleotide polymorphism) genotyping and identification, and downstream applications such as next generation high-throughput genomic sequencing and library construction. ## Claims ### Claim 1 A method of selectively amplifying one of two or more variants of a nucleic acid sequence in a nucleic acid sample, the method comprising: (a) hybridizing a forward selective primer to a nucleic acid sample comprising an amplification target sequence and a suppression target sequence, wherein the forward selective primer comprises: (i) a 3′ end priming sequence that is complementary to and hybridizes to a portion of the amplification target sequence and the suppression target sequence, and (ii) a 5′ end suppression sequence that is substantially identical to a portion of the suppression target sequence, wherein the portion of the suppression target to which the 5′ suppression sequence is substantially identical is 5′ of the portion of the suppression target sequence to which the 3′ end priming sequence hybridizes; (b) extending the hybridized forward selective primer of step (a) using a polymerase enzyme, the extension generating hybridized duplexes comprising: (i) the amplification target sequence and a hybridized complementary extension sequence, wherein the complementary extension sequence comprises, in the 5′ to 3′ direction, the forward selective primer and a sequence complementary to the amplification target sequence, and (ii) the suppression target sequence and a hybridized complementary extension sequence, wherein the complementary extension sequence comprises, in the 5′ to 3′ direction, the forward selective primer and a sequence complementary to the suppression target sequence; (c) denaturing the hybridized duplexes of step (b) to separate target sequences and complementary extension sequences; and (d) hybridizing a reverse primer to the complementary extension sequences of step (c), and extending the hybridized reverse primer using a 5′ to 3′ polymerase that lacks 5′ to 3′ exonuclease activity and substantially lacks strand displacement activity, wherein if the complementary extension sequence comprises the sequence complementary to the suppression target sequence, then amplification is suppressed by formation of a stem loop by the 5′ suppression sequence and a shorter amplification product is generated, and wherein if the complementary extension sequence comprises the sequence complementary to the amplification target sequence, then amplification is not suppressed by formation of a stem loop and a longer amplification product is generated, whereby the presence of one of two or more variants of a nucleic acid sequence is detected based on the selective amplification. ### Claim 2 (depends on 1) The method of claim 1, wherein steps (a)-(d) are repeated at least 10 times. ### Claim 3 (depends on 1) The method of claim 1, wherein the forward selective primer is at least 30 nucleotides in length. ### Claim 4 (depends on 1) The method of claim 1, wherein the longer amplification product generated in step (d) is at least 40 nucleotides in length. ### Claim 5 (depends on 1) The method of claim 1, wherein the extending of the hybridized reverse primer using the 5′ to 3′ polymerase that lacks 5′ to 3′ exonuclease activity and substantially lacks strand displacement activity of step (d) occurs for at least 5 seconds or more. ### Claim 6 (depends on 1) The method of claim 1, wherein the forward selective primer further comprises a loop spacer sequence, wherein said loop sequence is 5′ of the 3′ end priming sequence and does not comprise a sequence complementary to the complementary extension sequences. ### Claim 7 (depends on 1) The method of claim 1, wherein the reverse primer is a reverse selective primer. ### Claim 8 (depends on 1) The method of claim 1, wherein the forward selective primer comprises one or more locked nucleic acids (LNAs). ### Claim 9 (depends on 1) The method of claim 1, wherein the 5′ suppression sequence of the forward selective primer comprises one or more locked nucleic acids (LNAs). ### Claim 10 An assay for selectively amplifying one of two or more variants of a nucleic acid sequence in a nucleic acid sample, the assay comprising: (a) hybridizing a forward selective primer to a nucleic acid sample comprising an amplification target sequence and a suppression target sequence, wherein the forward selective primer comprises: (i) a 3′ end priming sequence that is complementary to and hybridizes to a portion of the amplification target sequence and the suppression target sequence, and (ii) a 5′ end suppression sequence that is at least 90% identical to a portion of the suppression target sequence, wherein the portion of the at least one suppression target to which the 5′ suppression sequence is at least 90% identical is 5′ of the portion of the suppression target sequence to which the 3′ end priming sequence hybridizes; (b) extending the hybridized forward selective primer of step (a) using a polymerase enzyme, the extension generating hybridized duplexes comprising: (i) the amplification target sequence and a hybridized complementary extension sequence, wherein the complementary extension sequence comprises, in the 5′ to 3′ direction, the forward selective primer and a sequence complementary to the amplification target sequence, and (ii) the suppression target sequence and a hybridized complementary extension sequence, wherein the complementary extension sequence comprises, in the 5′ to 3′ direction, the forward selective primer and a sequence complementary to the suppression target sequence; (c) denaturing the hybridized duplexes of step (b) to separate target sequences and complementary extension sequences; and (d) hybridizing a reverse primer to the complementary extension sequences of step (c), and extending the hybridized reverse primer using a 5′ to 3′ polymerase that lacks 5′ to 3′ exonuclease activity and substantially lacks strand displacement activity, wherein if the complementary extension sequence comprises the sequence complementary to the suppression target sequence, then amplification is suppressed by formation of a stem loop by the 5′ suppression sequence and a shorter amplification product is generated, and wherein if the complementary extension sequence comprises the sequence complementary to the amplification target sequence, then amplification is not suppressed by formation of a stem loop and a longer amplification product is generated, whereby the presence of one of two or more variants of a nucleic acid sequence is detected based on the selective amplification. ### Claim 11 (depends on 10) The assay of claim 10, wherein steps (a)-(d) are repeated at least 10 times. ### Claim 12 (depends on 10) The assay of claim 10, wherein the forward selective primer is at least 30 nucleotides in length. ### Claim 13 (depends on 10) The assay of claim 10, wherein the longer amplification product generated in step (d) is at least 40 nucleotides in length. ### Claim 14 (depends on 10) The assay of claim 10, wherein the extending of the hybridized reverse primer using the 5′ to 3′ polymerase that lacks 5′ to 3′ exonuclease activity and substantially lacks strand displacement activity of step (d) occurs for at least 5 seconds or more. ### Claim 15 (depends on 10) The assay of claim 10, wherein the forward selective primer further comprises a loop spacer sequence, wherein said loop spacer sequence is 5′ of the 3′ end priming sequence and does not comprise a sequence complementary to the complementary extension sequences. ### Claim 16 (depends on 10) The assay of assay of claim 10, wherein the assay is selected from a cancer screening assay, an autism screening assay, a prenatal genetic detection assay, and amicrobial detection assay. ### Claim 17 (depends on 10) The assay of assay of claim 10, wherein the amplification target sequence comprises a mutation or epigenetic modification found in cancer cells.